Shandong Sanyuan Biotechnology Co.Ltd. (301206) - Total Liabilities
Based on the latest financial reports, Shandong Sanyuan Biotechnology Co.Ltd. (301206) has total liabilities worth CN¥166.97 Million CNY (≈ $24.43 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 301206 cash flow metrics to assess how effectively this company generates cash.
Shandong Sanyuan Biotechnology Co.Ltd. - Total Liabilities Trend (2013–2024)
This chart illustrates how Shandong Sanyuan Biotechnology Co.Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check 301206 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Shandong Sanyuan Biotechnology Co.Ltd. Competitors by Total Liabilities
The table below lists competitors of Shandong Sanyuan Biotechnology Co.Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tae Kwang Corporation
KQ:023160
|
Korea | ₩68.22 Billion |
|
Shanghai Maling Aquarius Co Ltd
SHG:600073
|
China | CN¥6.98 Billion |
|
Costar Group Co Ltd
SHE:002189
|
China | CN¥2.17 Billion |
|
Johns LYNG Group Ltd
AU:JLG
|
Australia | AU$524.22 Million |
|
RIAMB (Beijing) Tech Dvlp Co
SHG:603082
|
China | CN¥2.69 Billion |
|
Suzhou Longway Electronic Machinery Co. Ltd. A
SHE:301202
|
China | CN¥597.95 Million |
|
Shandong Xiantan Co Ltd
SHE:002746
|
China | CN¥3.05 Billion |
|
Time Publishing and Media Co Ltd Class A
SHG:600551
|
China | CN¥2.51 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Shandong Sanyuan Biotechnology Co.Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shandong Sanyuan Biotechnology Co.Ltd. stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 21.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Sanyuan Biotechnology Co.Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
The table below shows the annual total liabilities of Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥314.04 Million ≈ $45.95 Million |
+15.29% |
| 2023-12-31 | CN¥272.40 Million ≈ $39.86 Million |
+9.34% |
| 2022-12-31 | CN¥249.14 Million ≈ $36.46 Million |
-57.69% |
| 2021-12-31 | CN¥588.83 Million ≈ $86.16 Million |
+116.90% |
| 2020-12-31 | CN¥271.48 Million ≈ $39.73 Million |
+54.61% |
| 2019-12-31 | CN¥175.59 Million ≈ $25.69 Million |
+75.38% |
| 2018-12-31 | CN¥100.12 Million ≈ $14.65 Million |
+53.29% |
| 2017-12-31 | CN¥65.31 Million ≈ $9.56 Million |
+61.52% |
| 2016-12-31 | CN¥40.44 Million ≈ $5.92 Million |
+64.09% |
| 2015-12-31 | CN¥24.64 Million ≈ $3.61 Million |
-19.67% |
| 2014-12-31 | CN¥30.68 Million ≈ $4.49 Million |
+60.62% |
| 2013-12-31 | CN¥19.10 Million ≈ $2.79 Million |
-- |
About Shandong Sanyuan Biotechnology Co.Ltd.
Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, and beverages; candy and chocolate food; baked food; health food; medical supplies; cosmetic products; chemical products; and other applications. The company exports its products to Europe, t… Read more